Diabetes can be particularly confusing for a teen where it can be easy to write off initial symptoms of low or high BG levels as fatigue from too much activity or illness-related.
Industry leaders are pursuing two paths for achieving better insulin control. Both smarter devices and smarter insulin have tremendous promise. It’s AI vs Biotech.
Major CGM and Pump companies are priced near record highs in the stock market. Investors seem to be forecasting that Automatic Insulin Dosing will be a huge financial windfall for these firms.
CGM’s or continuous glucose monitors are at the forefront of treating Type 1 Diabetes. We’ve compiled a list of things to consider when deciding if a CGM is right for you.
Dexcom recently acquired algorithm expert TypeZero Technologies and plans to integrate their Automated Insulin Delivery (AID) software into their CGMs by 2019.
Autoimmune diseases (AD) seem to receive less attention from the public despite rapidly increasing (up 21% between 2001 to 2009).
A yoga instructor outlines the benefits of yoga for individuals with Type 1 diabetes.
A Mississippi man recently filed a lawsuit against the device-maker for his wife’s 2017 death.
The IDx-DR will make it easier for non-eye care professionals to pre-screen for the condition.
MN research team creates cultural tool for Somali-speaking community with diabetes.
JDRF, ADA, and Helmsley issue RFP to research consistency and potency of insulin in U.S. pharmacies.
Dexcom CEO talks to IN about making diabetes technology more affordable and user-friendly for all.
Dexcom announces FDA approval of new device, which eliminates the need for fingerstick blood testing.
A woman with Type 1 diabetes offers tips for changing negative thought patterns.
A diabetes coach with T1D explains what this new therapy is all about.
Coaching apps can improve blood glucose management, but the emerging therapy can also be burdensome.
IN interviews an animal lover with Type 1 diabetes about the moral quandary of animal research.
A recent college graduate offers tips for staying on track with food choices on campus.
A recent publication explores how diabetes technology is transforming the research landscape.
According to researchers, insulin vials sold in U.S. pharmacies fail to meet FDA standards.
Sign up to receive email notifications about new Insulin Nation stories